Cardiologist Eric Topol with an op-ed in the NY Times, saying good riddance to Vioxx.
Related posts:
- Topol on Russert
- Waiting for the biopsy result is as stressful as being told you have cancer
- Avandia: A "flood" of lawsuits is coming
- "It’s availability, affability and ability"
- Acomplia and Steven Nissen
- A jury of "uneducated casino workers" beat the hell out of Merck
- Merck’s prevailing Vioxx strategy
KevinMD.com on Facebook
 
Follow on Twitter  
Subscribe








Comments on this entry are closed.